IRIS
RICEVUTO, ENRICO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.525
AS - Asia 5.050
EU - Europa 4.998
SA - Sud America 546
AF - Africa 72
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 6
Totale 19.208
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.432
SG - Singapore 2.119
CN - Cina 1.126
IE - Irlanda 1.081
RU - Federazione Russa 925
TR - Turchia 696
SE - Svezia 613
IT - Italia 524
DE - Germania 522
BR - Brasile 459
HK - Hong Kong 426
VN - Vietnam 395
UA - Ucraina 338
GB - Regno Unito 332
FR - Francia 266
FI - Finlandia 205
IN - India 77
CA - Canada 46
CZ - Repubblica Ceca 42
JP - Giappone 40
BD - Bangladesh 37
AR - Argentina 31
PL - Polonia 28
MX - Messico 26
BE - Belgio 24
IQ - Iraq 23
NL - Olanda 22
ZA - Sudafrica 19
MA - Marocco 16
ES - Italia 15
AT - Austria 12
EC - Ecuador 11
KR - Corea 11
SA - Arabia Saudita 11
CL - Cile 10
CO - Colombia 10
ID - Indonesia 10
UZ - Uzbekistan 10
AU - Australia 9
AE - Emirati Arabi Uniti 8
DZ - Algeria 7
KE - Kenya 7
LT - Lituania 7
PK - Pakistan 7
PY - Paraguay 7
RO - Romania 7
TH - Thailandia 7
DM - Dominica 6
EU - Europa 6
PE - Perù 6
PT - Portogallo 6
TN - Tunisia 6
VE - Venezuela 6
BG - Bulgaria 5
JO - Giordania 5
NP - Nepal 5
CR - Costa Rica 4
EE - Estonia 4
MY - Malesia 4
PH - Filippine 4
AZ - Azerbaigian 3
BO - Bolivia 3
CG - Congo 3
DO - Repubblica Dominicana 3
LU - Lussemburgo 3
PA - Panama 3
PS - Palestinian Territory 3
RS - Serbia 3
TW - Taiwan 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
BN - Brunei Darussalam 2
BY - Bielorussia 2
ET - Etiopia 2
HN - Honduras 2
HR - Croazia 2
IL - Israele 2
JM - Giamaica 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LB - Libano 2
LY - Libia 2
MD - Moldavia 2
MK - Macedonia 2
SY - Repubblica araba siriana 2
TJ - Tagikistan 2
TL - Timor Orientale 2
UY - Uruguay 2
BH - Bahrain 1
BW - Botswana 1
CI - Costa d'Avorio 1
DK - Danimarca 1
EG - Egitto 1
GA - Gabon 1
GF - Guiana Francese 1
GH - Ghana 1
GM - Gambi 1
HU - Ungheria 1
KH - Cambogia 1
LV - Lettonia 1
Totale 19.200
Salva come PNG Salva come JPEG
Città #
Jacksonville 1.308
Chandler 1.216
Singapore 1.204
Dublin 1.081
Dallas 815
San Jose 721
Ashburn 457
Hong Kong 421
Boardman 410
Santa Clara 382
Izmir 327
Nanjing 236
The Dalles 198
Wilmington 194
San Mateo 191
Lawrence 168
Princeton 168
Ann Arbor 164
Beijing 162
Moscow 158
New York 151
Lauterbourg 114
Ho Chi Minh City 112
Hanoi 107
Milan 90
Nanchang 87
Woodbridge 75
Munich 64
Los Angeles 63
Seattle 63
Bremen 61
Council Bluffs 57
Shenyang 56
São Paulo 55
Tianjin 55
Des Moines 49
Helsinki 48
Hebei 44
L'aquila 43
Verona 43
Brno 40
Kunming 37
Tokyo 36
Hefei 35
Columbus 33
Changsha 31
Frankfurt am Main 30
Jiaxing 29
Rome 29
Sant'egidio Alla Vibrata 27
Mountain View 26
Warsaw 25
Brussels 24
Dong Ket 22
Hangzhou 22
Jinan 22
London 22
Orem 22
Shanghai 22
Norwalk 21
Philadelphia 21
Brooklyn 19
Dearborn 19
Guangzhou 19
Zhengzhou 19
Chennai 18
Pune 17
San Francisco 17
Auburn Hills 15
Montreal 15
Denver 14
Pescara 14
Toronto 14
Da Nang 13
Falkenstein 13
L’Aquila 13
Phoenix 13
Amsterdam 12
Atlanta 12
Boston 12
Chicago 12
Lanzhou 12
Ningbo 12
Changchun 11
Falls Church 11
Haiphong 11
Johannesburg 11
Rio de Janeiro 11
Turku 11
Monza 10
Nuremberg 10
Curitiba 9
New Delhi 9
Poplar 9
Stockholm 9
Tashkent 9
Ankara 8
Assago 8
Belo Horizonte 8
Brasília 8
Totale 12.481
Salva come PNG Salva come JPEG
Nome #
Pyrroloquinoline Quinone (PQQ) Attenuates Hydrogen Peroxide-Induced Injury Through the Enhancement of Mitochondrial Function in Human Trabecular Meshwork Cells 384
The supportive care task force at the University of L'Aquila: 2-years experience 199
The prevalent KRAS exon 2 c.35 G > A mutation in metastatic colorectal cancer patients: a biomarker of worse prognosis and potential benefit of bevacizumab-containing intensive regimens? 192
KRAS and Two Rare PI3KCA Mutations Coexisting in a Metastatic Colorectal Cancer Patient With Aggressive and Resistant Disease. 176
Close correlation between MEK/ERK and Aurora-B signaling pathways in sustaining tumorigenic potential and radioresistance of gynecological cancer cell lines 170
Neoadjuvant chemotherapy in breast cancer: a dose-dense schedule in real life and putative role of PIK3CA mutations. 169
Bone targeted therapy for preventing skeletal-related events in metastatic breast cancer 166
Prognostic significance of clinicopathological factors in early breast cancer: 20 years of follow-up in a single-center analysis. 166
Tyrosine kinase inhibitor CEP-701 blocks the NTRK1/NGF receptor and limits the invasive capability of prostate cancer cells in vitro 165
Real-life multidisciplinary treatment for unresectable colorectal cancer liver metastases including hepatic artery infusion with chemo-filtration and liquid biopsy precision oncotherapy: observational cohort study 161
P16 hypermethylation contributes to the characterization of gene inactivation profiles in primary gastric cancer 157
Antiproliferative and pro-apoptotic effects of 5-azacytidine in prostate carcinoma cells in vitro involve the recovering of PTEN-mediated Akt activity control and androgen sensitivity 157
Multidisciplinary Treatment, Including Locoregional Chemotherapy, for Merkel-Polyomavirus-Positive Merkel Cell Carcinomas: Perspectives for Patients Exhibiting Oncogenic Alternative Δ exon 6–7 TrkAIII Splicing of Neurotrophin Receptor Tropomyosin-Related Kinase A 153
Dose-finding study of oxaliplatin associated to capecitabine based preoperative chemoradiotherapy in locally advanced rectal cancer 151
New schedule of bevacizumab/paclitaxel as first-line therapy for metastatic HER2-negative breast cancer in a real-life setting 148
Oncology together for L'Aquila: early resumption of integrated oncological activities after the earthquake 146
CXCR4 pharmacogical inhibition reduces bone and soft tissue metastatic burden by affecting tumor growth and tumorigenic potential in prostate cancer preclinical models 145
Circulating tumour cell gene expression and chemosensitivity analyses: predictive accuracy for response to multidisciplinary treatment of patients with unresectable refractory recurrent rectal cancer or unresectable refractory colorectal cancer liver metastases 144
Multidisciplinary palliation for unresectable recurrent rectal cancer: Hypoxic pelvic perfusion with mitomycin C and oxaliplatin in patients progressing after systemic chemotherapy and radiotherapy, a retrospective cohort study 143
Epigenetic modulation of PTEN expression during antiandrogenic therapies in human prostate cancer 143
Novel BRCA1 and BRCA2 germline mutations and assessment of mutation spectrum and prevalence in Italian breast and/or ovarian cancer families 140
two simulteneous and very uncommom pi3kca mutations in a liver metastasis from colorectal cancer patient with aggressive and resistant disease 139
Effects of Chemotherapy in Patients with Concomitant Aortic Aneurysm and Malignant Disease 139
KRAS, NRAS and BRAF mutations detected by next generation sequencing, and differential clinical outcome in metastatic colorectal cancer (MCRC) patients treated with first line FIr-B/FOx adding bevacizumab (BEV) to triplet chemotherapy. 139
Dose-dense nonpegylated liposomal doxorubicin and docetaxel combination in breast cancer: Dose-finding study 137
Hypoxic pelvic perfusion with cisplatin and mitomycin C in multidisciplinary palliative treatment of patients with unresectable recurrent rectal cancer: A retrospective study 136
Dual PI3K/mTOR inhibitor, XL765 (SAR245409), shows superior effects to sole PI3K [XL147 (SAR245408)] or mTOR [rapamycin] inhibition in prostate cancer cell models 136
Mutazioni della p53 in campioni selezionati di adenocarcinoma del colon dell’Italia Centrale 135
A gene expression signature from bone metastases as predictor of clinical outcome in breast cancer patients 135
Differential prognosis of metastatic colorectal cancer patients post-progression to first-line triplet chemotherapy plus bevacizumab, Fir-B/FOx, according to seconde-line treatment and KRAS genotype 133
Pain evaluation and management: a survey of Italian radiotherapists 133
Precision oncotherapy based on liquid biopsies in multidisciplinary treatment of unresectable recurrent rectal cancer: a retrospective cohort study 133
p16 (INK4a, MTS-1) gene polymorphism and methylation status in human pituitary tumors 132
New mutations and protein variants of NBSI are identified in cancer cell lines 129
Trifluoroibuprofen inhibits α-Methylacyl Coenzyme A Racemase (AMACR/P504S), Reduces Cancer Cell Proliferation and Inhibits in Vivo Tumor Growth in Aggressive Prostate Cancer Models. 127
Recurrent Metastatic Pulmonary Synovial Sarcoma during Pregnancy: A Case Report and Literature Review 125
Bioclinical parameters driving decision-making of subsequent lines of treatment in metastatic castration-resistant prostate cancer 125
Gabapentin in the treatment of severe sweating experienced by advanced cancer patients 125
Worse prognosis of KRAS c.35 G > A mutant metastatic colorectal cancer (MCRC) patients treated with intensive triplet chemotherapy plus bevacizumab (FIr-B/FOx). 125
Assessment and treatment of symptoms among italian medical oncologists 124
Symptoms in advanced cancer: The influence of sex, age, Karnofsky Performance Status and PaP score. 124
Uncoupling of the epidermal growth factor receptor from downstream signal transduction molecules guides the acquired resistance to gefitinib in prostate cancer cells 124
Oxaliplatin (l-OHP) association with paclitaxel (PTX) or docetaxel (DTX) in NSCLC cell lines: Schedule-dependent activity based on p53/microtubule associated protein 4 (MAP4) interaction 124
Cardiovascular toxicity following sunitinib therapy in metastatic renal cell carcinoma: a multicenter analysis 124
A phase II study of dose-dense epirubicin plus cyclophosphamide followed by docetaxel plus capecitabine and pegfilgrastim support as preoperative therapy for patients with stage II, IIIA breast cancer 123
Apoptosis induced by oxaliplatin in human colon cancer HCT15 cell line 123
An association of epirubicin, etoposide and cisplatin in gastric cancer: a phase II study 122
Meccanismo d’azione e farmacologia di nuovi composti organometallici nel trattamento del carcinoma del colon-retto. 122
Prognostic relevance of PIK3CA mutations in breast cancer patients treated with primary dose-dense epirubicin/cyclophosphamide -> dose-dense docetaxel 122
Recommendations for the implementation of BRCA testing in ovarian cancer patients and their relatives 122
Hiccup in patients with advanced cancer successfully treated with gabapentin: report of three cases 122
Poker association of weekly alternating 5-fluorouracil, irinotecan,bevacizumab and oxaliplatin (FIrB/FOx) in first line treatment of metastatic colorectal cancer: a phase II study 121
A KRAS and dual concomitant PI3KCA mutations in a metastatic colorectal cancer patient with aggressive and resistant disease 120
Axitinib after Sunitinib in metastatic renal cancer: Preliminary results from Italian "Real-World" SAX Study 120
Safety and efficacy of nivolumab for metastatic renal cell carcinoma: real-world results from an expanded access programme 120
Prevalence of BRCA1 and BRCA2 genomic rearrangements in a cohort of consecutive Italian breast and/or ovarian cancer. families 119
Increased expression of a set of genes enriched in oxygen binding function discloses a predisposition of breast cancer bone metastases to generate metastasis spread in multiple organs 119
Novel P53 mutations detected by FAMA in colorectal cancers 116
In vivo bone metastases, osteoclastogenic ability, and phenotypic characterization of human cancer cells 116
Recommendations for the implementation of BRCA testing in the care and treatment pathways of ovarian cancer patients 116
Clinical parameters to guide decision-making in elderly metastatic colorectal CANCER patients treated with intensive cytotoxic and anti-angiogenic therapy 116
Prognostic relevance of KRAS genotype in metastatic colorectal cancer patients unfit for FIr-B/FOx intensive regimen 116
Prognostic relevance of KRAS genotype and the prevalent C.35 G > a mutation in metastatic colorectal cancer (MCRC) patients fitting for intensive FIr-B/FOx triplet chemotherapy plus bevacizumab 114
Short-term weekly neoadjuvant chemotherapy in the treatment of locally advanced cervical cancer 114
Multidisciplinary management of hepatocellular carcinoma in clinical practice 114
Efficacy of treatment with tetracyclines to prevent acneiform eruption secondary to cetuximab therapy 113
NEW MUTATIONS AND PROTEIC VARIANTS OF NBS1 ARE IDENTIFIED IN CANCER CELL LINES 112
Poorly differentiated neuroendocrine rectal carcinoma with uncommon immune-histochemical features and clinical presentation with a subcutaneous metastasis, treated with first line intensive triplet chemotherapy plus bevacizumab FIr-B/FOx regimen: An experience of multidisciplinary management in clinical practice 112
Choice of chemotherapy schedules in elderly patients (> 75 years) with metastatic colorectal cancer (mcrc) according to comorbidity 111
Can analysis of the molecular status of the p53 gene contribute to improving the therapeutic strategy for breast carcinoma? 111
Triplet schedule of weekly 5-fluorouracil and alternating irinotecan or oxaliplatin in advanced colorectal cancer: a dose-finding and phase II study 110
Plasma proteomic profiling in hereditary breast cancer reveals a BRCA1-specific signature: Diagnostic and functional implications 109
A six-gene signature predicting breast cancer lung metastasis 108
Intensive first-line FIr-C/FOx-C association of triplet chemotherapy plus cetuximab in RAS wild-type metastatic colorectal cancer patients: preliminary phase II data and prediction of individual limiting toxicity syndromes by pharmacogenomic biomarkers. 108
Relevance of Pharmacogenomics and Multidisciplinary Management in a Young-Elderly Patient WithKRASMutant Colorectal Cancer Treated With First-Line Aflibercept-Containing Chemotherapy 108
ABERRANT HYPERMETHYLATION OF THE P16 GENE IN SPORADIC GASTRIC CANCER 107
Tailoring the dosing schedule of nab-paclitaxel in metastatic breast cancer according to patient and disease characteristics: Recommendations from a panel of experts 107
Role of immunoscintigraphy in clinical assessment of gastrointestinal tumors 107
Effects of EGFR tyrosine kinase inhibitor erlotinib in prostate cancer cells in vitro 106
Significato prognostico e predittivo delle alterazioni genetiche nel carcinoma gastrico 106
Medical emergencies in oncology: hypercalcemia. II. Diagnosisand therapy 106
Familiarity and heredity of tumors in function of an early surgical therapeutic approach 106
Toxicity Syndromes, Patient-Related Clinical Indicator of Toxicity Burden Induced by Intensive Triplet Chemotherapy-Based Regimens in Gastrointestinal Cancers With Metastatic Disease 106
Real life triplet FIr/FOx chemotherapy in first-line metastatic pancreatic ductal adenocarcinoma patients: Recommended schedule for expected activity and safety and phase II study 105
In vitro and in vivo effects of bicalutamide on the expression of TrkA and P75 neurotrophin receptors in prostate carcinoma 104
Phenotypic characterization of human prostatic stromal cells in primary cultures derived from human tissue samples. 103
Role of estrogen receptor alpha in aggressiveness and osteoclastogenic potential of human breast carcinoma cells. 103
Different expressivity of BRCA1 and BRCA2: analysis of 179 Italian pedigrees with identified mutation 103
Immune-related adverse events correlate with clinical outcomes in NSCLC patients treated with nivolumab: The Italian NSCLC expanded access program 103
Intraperitoneal chemotherapy [LA CHEMIOTERAPIA INTRAPERITONEALE] 102
Effectiveness of liver metastasectomies in patients with metastatic colorectal cancer treated with FIr-B/FOx triplet chemotherapy plus bevacizumab. 102
Weekly administration of paclitaxel: peculiarity and biological premises 102
Reducing breast cancer incidence in familial breast cancer: overlooking the present panorama 101
Valutazioni seriate del peptide natriuretico cerebrale sono predittive di cardiotossicità da antracicline in pazienti sottoposti a chemioterapia non ad alte dosi 101
Carcinoma della pelvi renale e dell'uretere 101
Modulation of GemOx chemotherapy according to CIRS in elderly patients with advanced pancreatic cancer 100
Awareness of disease severity in Italian breast cancer patients submitted to mastectomy or conservative surgery 100
Effectiveness and safety of intensive triplet chemotherapy plus bevecizumab, FIr-B/FOx, in young-elderly metastatic colorectal cancer 100
Pharmacogenomic Assessment of Patients with Colorectal Cancer and Potential Treatments 100
Triplet Chemotherapy in Patients With Metastatic Colorectal Cancer: Toward the Best Way to Safely Administer a Highly Active Regimen in Clinical Practice 99
Totale 12.757
Salva come PNG Salva come JPEG
Categoria #
all - tutte 77.245
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 77.245
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021438 0 0 0 0 0 0 0 0 0 68 283 87
2021/20221.110 67 88 276 73 32 18 12 55 66 21 76 326
2022/20233.321 233 205 61 358 346 378 5 212 1.375 13 78 57
2023/2024717 116 44 33 103 50 178 16 63 0 28 27 59
2024/20253.197 97 73 308 134 439 268 469 286 678 83 199 163
2025/20265.700 310 635 553 714 553 496 1.148 214 494 583 0 0
Totale 19.453